MNK-795

Mallinckrodt's extended-release pain drug meets main goal of study
Reuters
Fri, 09/6/13 - 10:25 am
Mallinckrodt
MNK-795
FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
Yahoo
Mon, 07/29/13 - 10:50 am
FDA
MNK-795
Mallinckrodt
oxycodone
Depomed